These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 27838471

  • 1. Study of serum syndecan-1 levels in a group of Egyptian juvenile systemic lupus erythematosus patients.
    Mosaad NA, Lotfy HM, Farag YM, Mahfouz RH, Shahin RM.
    Immunol Lett; 2017 Jan; 181():16-19. PubMed ID: 27838471
    [Abstract] [Full Text] [Related]

  • 2. Urinary interleukin 22 binding protein as a marker of lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Badr AMM, Farag Y, Abdelshafy M, Riad NM.
    Clin Rheumatol; 2018 Feb; 37(2):451-458. PubMed ID: 28887660
    [Abstract] [Full Text] [Related]

  • 3. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO, Corrente JE, Saad-Magalhães C.
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [Abstract] [Full Text] [Related]

  • 4. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [Abstract] [Full Text] [Related]

  • 5. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L, Enocsson H, Skogh T, Padyukov L, Jönsen A, Urowitz MB, Gladman DD, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace D, Isenberg DA, Rahman A, Merrill J, Ginzler E, Alarcón GS, Chatham WW, Petri M, Khamashta M, Aranow C, Mackay M, Dooley MA, Manzi S, Ramsey-Goldman R, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian K, Inanc M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T, Bruce IN, Wetterö J, Sjöwall C.
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum levels of syndecan-1 are associated with renal involvement in patients with systemic lupus erythematosus.
    Kim KJ, Kim JY, Baek IW, Kim WU, Cho CS.
    J Rheumatol; 2015 Feb; 42(2):202-9. PubMed ID: 25512478
    [Abstract] [Full Text] [Related]

  • 7. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C.
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage.
    Gheita TA, Abdel Rehim DM, Kenawy SA, Gheita HA.
    Acta Reumatol Port; 2015 Feb; 40(2):145-9. PubMed ID: 26219967
    [Abstract] [Full Text] [Related]

  • 9. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL, Kiss MHB, Carrasco S, Palmeira P, Goldenstein-Schainberg C, Carneiro-Sampaio M.
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [Abstract] [Full Text] [Related]

  • 10. Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry.
    Kim SK, Choe JY, Lee SS.
    Yonsei Med J; 2018 Sep; 59(7):857-864. PubMed ID: 30091319
    [Abstract] [Full Text] [Related]

  • 11. Comparison between disease onset patterns of Egyptian juvenile and adult systemic lupus erythematosus (single centre experience).
    Abdel-Nabi HH, Abdel-Noor RA.
    Lupus; 2018 May; 27(6):1039-1044. PubMed ID: 29460702
    [Abstract] [Full Text] [Related]

  • 12. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus.
    Liphaus BL, Lima L, Palmeira P, Silva CA, Goldenstein-Schainberg C, Carneiro-Sampaio M.
    Clin Rheumatol; 2020 Feb; 39(2):509-514. PubMed ID: 31655933
    [Abstract] [Full Text] [Related]

  • 13. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW, UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.
    Arthritis Rheum; 2012 Jul; 64(7):2356-65. PubMed ID: 22294381
    [Abstract] [Full Text] [Related]

  • 14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 15. Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus.
    Hassan W, Behiry E, Mahgoub M.
    Arch Rheumatol; 2021 Mar; 36(1):47-55. PubMed ID: 34046568
    [Abstract] [Full Text] [Related]

  • 16. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
    Mohamed AE, Hasen AM, Mohammed GF, Elmaraghy NN.
    Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?
    Kanakoudi-Tsakalidou F, Farmaki E, Tzimouli V, Taparkou A, Paterakis G, Trachana M, Pratsidou-Gertsi P, Nalbanti P, Papachristou F.
    Lupus; 2014 Mar; 23(3):305-12. PubMed ID: 24399813
    [Abstract] [Full Text] [Related]

  • 18. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 19. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM, Abdel-Rahim MH, Elsayh KI, Hassanien MM, Mahran SA, Hetta HF.
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [Abstract] [Full Text] [Related]

  • 20. Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations.
    Joo YB, Bae SC.
    Int J Rheum Dis; 2015 Feb; 18(2):117-28. PubMed ID: 25524656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.